Submit your Manuscript to Current Oncology – A Canadian Publication with International Exposure When authors are deciding where to publish their work

   
CO-Header-new

Submit your Manuscript to Current Oncology – A Canadian Publication with International Exposure

When authors are deciding where to publish their work, the international reach of the journal is an important factor. By publishing with Current Oncology, your work will reach and impact Canadian Oncology practice, as well as receive international exposure as exemplified by:

• 12,000 journal website visits per month from 149 different countries (30% USA, 27% Canada and 43% Int’l)
• Over 88,000 article views in PubMed Central per month – full text articles are being viewed through PubMed related searches

Other benefits of publishing with Current Oncology include:

• High standard of peer review
• Articles freely and permanently accessible online immediately upon publication
• Distributed in print gratis to the Canadian oncology community
• Included in major bibliographic databases such as PubMed and PubMed Central (PMC)
• Impact factor of 1.829 (Journal Citation Reports, Thomson Reuters, 2016)
• Articles are widely promoted through email notifications, table of contents alerts, and social media

Authors are encouraged to submit high-quality manuscripts that report advances in research that are relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.

To submit your manuscript for consideration by the Editors of Current Oncology, go to our “Information for Authors” page.

Current Oncology Editorial Board Meeting

On June 15th, Current Oncology held an Editorial Board Meeting to discuss current submissions, methods for attracting high-quality Canadian research, extending journal reach, and the future direction and goals for the journal. Multimed also provided a Publisher Report to analyze journal stats, submissions, and summarize current and future initiatives.

The feedback provided by our Editorial team was invaluable towards the continued success of the journal. Based on the feedback received, the journal is currently working on the following initiatives, and will keep our readership informed on the progress in future newsletters:

• Partnerships with Canadian Oncology associations and organizations
• Attracting high-quality submissions from young investigators and Canadian researchers
• Expanding reach within Canada and Internationally
• Increasing impact factor and other important journal metrics
• Update to reviewer database
• Reviewer recognition program

Our Editorial Board is working hard to ensure that we have a clear focus going forward into 2017 and beyond. We would like to take this opportunity to thank all Editors for their continuing contribution to Current Oncology: Martin Chasen, Phil Gold, Richard Ablin, Timothy Asmis, R. Daniel Bonfil, Eric Bouffet, Jonathan Bramson, Rona Cheifetz, Winson Cheung, Timothy Christie. Esther Dajczman, Naheed Dosani, Samy El-Sayed. Robin Fainsinger, Ronald Feld, William Foulkes, Sharlene Gill, Martin Gleave, Eva Grunfeld, Hananel Holzer, Doris Howell, Elisabeth Isenring, Natasha Leighl, Bennie Lindeque, Victor Ling, Jeff Lipton, Peter Metrakos, Nicole Mittmann, Karin Olson, Wendy Parulekar, Martine Puts, Daniel Rayson, Fred Saad, Fiona Schulte, Dugald Seely, Mary Shariff, George Shenouda, Douglas Strother, and Tallal Younis.

logo70

Multimed Inc.
Publisher of Current Oncology
www.multi-med.com

***
Hot-off-the-Press

Volume 23, Number 5 (October 2016)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:
http://www.current-oncology.com/index.php/oncology/issue/current/showToc

***
Looking-Ahead

Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 23, Number 6 (December 2016) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

***
COTwiiterPageShot
 
twitter banner e-newsletter
***
Editorial-Spotlight
Cheifetz Rona 1510

Rona Cheifetz, MD Med FRCSC FACS
Editor of our Surgical Oncology Section (since March 2012)

Rona Cheifetz MD Med FRCSC FACS is a graduate of the University of Toronto, Faculty of Medicine and completed her general surgery training at the University of British Columbia (UBC). She then obtained a Masters Degree in Adult Education from UBC and completed a Surgical Oncology Fellowship in Toronto. She is an Associate Professor in the Department of Surgery at UBC. She has held the positions of Chief of the Surgical Oncology Service at Vancouver General Hospital and Head of CME for the Department of Surgery and for the BC Surgical Oncology Network’s CME Committee which was responsible for developing a provincial CME program in surgical oncology and the development of the BC Surgical Oncology Newsletter. She is past president of the Canadian Society of Surgical Oncology. She has recently left her clinical surgical oncology practice and is now the Medical Lead for the Hereditary Cancer Program High Risk Clinic for the BC Cancer Agency.

***
Have-You-Heard

Current Oncology Welcomes Dr. Martine Puts to our Editorial Team

We are pleased to welcome Dr. Martine Puts (University of Toronto) to the Editorial Team as editor of the journal’s Geriatric Oncology section. To view Current Oncology’s full list of Section Editors, please click here.

Are you a Reviewer for Current Oncology? Time to Update your Account.

We request that all reviewers update their profile frequently to ensure the system is up to date with their contact information and reviewing interests. Keeping your reviewing interests up to date will ensure that you are being matched to manuscripts based on your expertise, and also improve your chances of being invited to review a manuscript. To update your reviewing interests, please visit http://current-oncology.com/index.php/oncology/pages/view/reviewers#update. IMPORTANT NOTE: For reviewers who have not entered reviewing interests, we ask that you login to your account and add your interests by no later than October 31, 2016. After this date, reviewers without reviewing interests provided, will be removed from our database.

Canadian Oncology Members: Promote your Work through @CurrentOncology

Are you presenting your Canadian study or results at a major Canadian or International Conference? Please let us know so we can help keep members of the Canadian oncology community updated on ongoing work of their peers through twitter. We encourage you to send details of the meeting and presentation topic to current_oncology@multi-med.com, so we can help spread the word.

Current Oncology Partners with Meetings across Canada

As Canada’s premier Oncology journal, we invite Oncology meetings, symposiums and conferences, from across Canada to partner with Current Oncology through a marketing exchange. The journal provides an excellent venue and opportunity to increase the visibility of your meeting to members of the Canadian oncology community. For further information about marketing exchange opportunities with Current Oncology please view our “Current Oncology Marketing Exchange Opportunities” information package, or contact Amanda Shand.

***
Readers-Choice

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (September 2016)

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45

Management of arthralgias associated with aromatase inhibitor therapy
Thorne C.
Curr Oncol. 2007 Dec;14 Suppl 1:S11-9

A legal right to die: responding to slippery slope and abuse arguments
Benatar D.
Curr Oncol. 2011 Oct;18(5):206-7

Most Read Recently* Published Articles at www.current-oncology.com

Use of cannabinoids in cancer care: palliative care
Aggarwal SK.
Curr Oncol. 2016 Mar;23(Suppl 2):S33-6. doi: 10.3747/co.23.2962. Epub 2016 Mar 16.

Anticancer mechanisms of cannabinoids
Velasco G, Sánchez C, Guzmán M
Curr Oncol. 2016 Mar;23(Suppl 2):S23-32. doi: 10.3747/co.23.3080. Epub 2016 Mar 16.

Integrating cannabis into clinical cancer care
D.I. Abrams
Curr Oncol. 2016 Mar;23(Suppl 2):S8-14. doi: 10.3747/co.23.3099. Epub 2016 Mar 16.

*Published within past 12 months

***
Quick-Links
***

Contact Us

Email-CON
 
Address-CON
 
Phone-CON
 
Web-CON
twitter
1px